Two Pillars for Evolving Sustainability
Astellas prioritized the 9 material issues (Materiality) from the materiality matrix. As we believe that the act of prioritizing and subsequently addressing these 9 material issues will put Astellas on the path to transforming to be a Cutting-Edge, VALUE-driven life science innovator and strengthening resilient and sustainable business operations to meet the expectations of society. Please click here about our key issues and materiality.
1. Transforming to be a Cutting-Edge, VALUE-driven life science innovator
This is Astellas' business model for enhancing sustainability and providing innovative healthcare solutions by creating and realizing "VALUE". We will promote initiatives to address the following five material issues.
2. Strengthening resilient and sustainable business operations to meet the expectations of society
Astellas strengthens our business operations to ensure the stable supply of our products to patients under any circumstances. We will promote initiatives to address the following four material issues.
Environmental Sustainability
Companies are required to be actively involved in environmental issues. Recognizing that harmony between the global environment and our business activities is a prerequisite to our corporate existence, we shall take proactive measures to conserve the global environment. In addition to the nine material issues listed above, we will promote initiatives for the following two important issues
Approach for Two Pillars
We have set the Med-term Priorities for Astellas, Initiatives, and Our Commitments by FY2025 as for the two pillars and Environmental Sustainability. We will update our progress against our commitments in the future.
1. Transforming to be a Cutting-Edge, VALUE-driven life science innovator
| Most important issues | Mid-term Priorities for Astellas | Initiatives | Our Commitments by FY 2025 |
|
Access to Health Talent and organizational culture for realizing innovation Fulfilling unmet medical needs by creating novel healthcare solutions Transformative treatment through innovative therapeutic methods Value-based pricing |
Translate innovative science into VALUE through the Focus Area approach to R&D, introducing novel therapies and modalities to treat diseases with high unmet medical needs | Addressing unmet medical needs for provision of solutions that produce better outcomes than previously possible | Aim to improve the lives of patients and caregivers around the world and contribute to reducing the overall load on the healthcare system |
|
Maximize patient access to Astellas’ innovations and enable them to achieve better outcomes Beyond the biopharmaceutical space, develop and commercialize novel healthcare solutions |
Providing comprehensive access programs throughout the product lifecycle Supporting healthcare system-strengthening programs in partnership and Astellas Global Health Foundation |
Provide as many patients as possible with access to our products |
|
| Advocate a value-based pricing for stakeholders to ensure innovative medicines in new modalities contribute to the health of patients around the world and realize the sustainable healthcare system | Advocating for value-based pricing as a basis to support access to medical innovations | Contribute to sustain healthcare systems through advocating for value-based pricing | |
|
Create an environment within Astellas that fosters innovation Align strategy with the right capabilities, embraced in a culture that promotes innovation |
Optimizing the number of people under one manager's control and reducing layers, reinforcement of succession planning, and cultivation of a culture ensuring psychological safety and encouraging active feedback | Foster talents and an organizational culture with trusted capabilities to deliver innovation |
2. Strengthening resilient and sustainable business operations to meet the expectations of society
| Most important issues | Mid-term Priorities for Astellas | Initiatives | Our Commitments by FY 2025 |
|
Compliance and ethical business practices Product quality assurance and product safety Responsible supply chain management Safe and appropriate use of products |
Sustains a resilient business that continuously supplies products during unpredictable or emergency situations |
Enhancing energy sourcing through investigating reinforcement of emergency power generation and introduction of renewable energy such as solar panels to own facilities Enhancing material sourcing and product supply networks through the various means including double sourcing and diversified distribution bases |
Establish a more sustainable and resilient value chain |
| Further enhance capability to secure patient safety and product quality as well as optimizing customer interaction for maximizing VALUE for patients |
Fostering a Culture of Quality through leadership commitment, employee engagement and patient centric mindset |
Ensure patient safety and product quality by fostering a Culture of Quality and by evolving customer experience |
Environmental Sustainability
| Important issues | Mid-term Priorities for Astellas | Initiatives | Our Commitments by FY 2025 |
|
Reduction of environmental burden Climate change and energy |
Reduce greenhouse gas emissions toward a goal consistent with the Paris Agreement’s and achieve net-zero emissions by 2050 | Enhancing energy efficiency and shifting to renewable energy sources such as solar and wind power, Reducing the carbon footprint of the supply chain |
Achieve by FY2025 the amount of reasonable reduction of greenhouse gas emissions target* *GHG emission reduction targets by FY2030 ・Scope1+2 ・Scope 3 |
